DCF — ST. MARYS MEDICAL CENTER
Enterprise Value: $-339.7M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-339.7M
Enterprise Value
$-116.9M
PV of Cash Flows
$-222.8M
PV of Terminal Value
$-358.9M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $492.7M | $-16.0M | -3.0% | $-36.9M | $-33.5M |
| Year 2 | $507.5M | $-11.4M | -2.0% | $-32.9M | $-27.2M |
| Year 3 | $522.7M | $-6.5M | -1.0% | $-28.7M | $-21.5M |
| Year 4 | $538.4M | $-4.1M | -1.0% | $-26.8M | $-18.3M |
| Year 5 | $554.5M | $-2.8M | -1.0% | $-26.3M | $-16.3M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-339.7M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$478.3M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.037524392801056204
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5